Navigation Links
Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
Date:11/16/2007

- Republic of Georgia Drug Agency Approves Protocol for New Clinical Trial

of Bavituximab in Combination with Docetaxel -

TUSTIN, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that its Phase II clinical protocol to study bavituximab in combination with the chemotherapy drug docetaxel in patients with metastatic breast cancer has been approved by the Drug Agency of the Ministry of Labour, Health and Social Affairs of Georgia. The open label, multi-center safety and efficacy trial is expected to begin enrolling patients by early 2008.

The primary objective of the trial is to assess the overall response rate to the combination of bavituximab with docetaxel, a chemotherapy drug commonly used in the treatment of metastatic breast cancer. Secondary objectives include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. In the trial's two-stage design, up to 15 patients with metastatic breast cancer will be enrolled initially. The study will then be expanded up to a total of 46 patients if promising results are observed. The trial is expected to enroll patients at a minimum of three clinical trial sites.

"We are eager to assess bavituximab's potential in Phase II combination studies in a number of cancer indications, and we are very pleased to have received prompt regulatory approval to proceed with this breast cancer trial," said Steven W. King, president and CEO of Peregrine. "The clinical sites in the Republic of Georgia that will be par
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... 3D Global Solutions is pleas...ram managing the proposal effort for ReSound who r...igital Hearing Aid contract. The award includes no...epartment of Defense and other federal agencies. ...ember 8, 2009 -- 3D Global Solutions is pleased to...
(Date:11/8/2009)..., "One victory does not mean the battle is won," ...7 In a vote of 240-194,...nski-Smith Amendment to prohibit abortion mandates... ,, Americans United for Life Action President ...this amendment is a victory for the pro-life Ameri...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 Th...irector, Operation Rescue Insurrecta Nex. ,, M...y have been fighting to keep child-killing by abor... Mr. Terry states: "This is a great first step to ... we have a lot of fighting ahead of us. Our rejoic...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 Ka... Insurance Plans (AHIP), released the following st... "Health plans strongly support comprehensive heal...scussion by proposing a complete overhaul of how h... proposed guaranteed coverage, elimination of pre-...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a "...ion (AMA), the AMA President J. James Rohack, M.D....icians from all state and medical specialty societ...-making meeting, where health system reform will t...om/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over t...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
... for pie and mash, and missing visits to British p...cently confessed to being homesick following his m...mentary to be shown on Tuesday at 9 p.m., Becks ad... love eating when I come back to London. ...
...ians and Iraqis, will face prejudice in the wake o... and Glasgow. According to the medical jo...being used as an excuse to discriminate against ov...as been under way in the United Kingdom since the ...
...t of American youths online have been asked to sen... Internet. Researchers at the University ...h Center have found that one in 25 youth who use t...olescent Health, poses a new threat for young peop...
...icing Ayurveda, a native system of medicine, has b...ent by a city court for causing the death of a pre...incident took place two years ago. The doc..., Babli had approached the private medical practit...
... be seen in action spearheading a charity campaign... hair as a result of cancer treatment. T...le to grow their locks, get it cut, and donate it ... too. "I have lost multiple family member...
...ans glamorous clothes, high heels and choreographe... women's contest with the aim of reducing infant ...ompetition evaluates mothers' weights during pregn...m nearby hospitals, NGO members working in the slu...
Other Medicine News:Health News:Indian, Iraqi Medics may Face Terror Stigma Overseas 2Health News:Four Percent of American Youths are Requested to Post Sexual Snaps on Web 2Health News:Pregnant Women's Contest to Curb Infant Mortality 2
(Date:11/6/2009)...S.C., Nov. 6 The ,Hel...uth Carolina and Georgia throughout the week of No...nsured and financially-struggling patients access ...medicines for free or nearly free. With the nation... Partnership for Prescription Assistance (PPA) bus...
(Date:11/6/2009)....J., Nov. 6 Derma Scie...r of advanced wound care products, announced plans...market on Monday, November 16, 2009. The Company w...s the results at 11:00 am EST. Interested parties ...-1684 (international), with passcode 81416481 to a...
(Date:11/6/2009)...ov. 6 NuVasive, Inc. (Na... developing products for minimally disruptive surg... appointment of Michael J. Lambert as Executive Vi...e November 9, 2009. The Company also announced se..., "Michael will be an excellent complement to the...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Boy Scouts Uniform Earns Award 48315 1Boy Scouts Uniform Earns Award 48315 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5UNC scientists identify growth factor as possible cancer drug target 48310 1
...able Stent Technology Holds Promise as,Future-Gene...tients,with Coronary Artery Disease, ABBOTT PARK, ...ott today announced positive results from ABSORB, ...erall safety and performance,of a fully bioabsorba... of coronary artery disease. Six- month results fr...
...Patients Treated for Acute Coronary Syndromes,(ACS...W ORLEANS, March 26, 2007 /PRNewswire/ -- One-year... acute coronary syndrome,(ACS) patients in the "An... similar rates of ischemic clinical outcomes compa...ming previous findings,which showed similar ische...
Other Medicine Technology:Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: